GRANULES INDIA

Granules India Limited is a leading pharmaceutical manufacturing company based in India.

It is a FACTORY (Manufacturer).

Granules India specializes in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). The company operates on a fully integrated business model, from API to finished product, serving both regulated and semi-regulated markets globally. With multiple manufacturing facilities in India, Granules India is known for its strong focus on process innovation, quality, and cost-effective production across various therapeutic segments.

Granules India produces and sells a range of Active Pharmaceutical Ingredients including Paracetamol (Acetaminophen), Ibuprofen, Metformin Hydrochloride, Guaifenesin, Methocarbamol, Naproxen, Phenylephrine Hydrochloride, Pseudoephedrine Hydrochloride, Cetirizine Hydrochloride, Fexofenadine Hydrochloride, and Loratadine. The company also manufactures Pharmaceutical Formulation Intermediates and Finished Dosages. These finished dosage forms encompass tablets, capsules, and oral suspensions, primarily serving therapeutic areas such as pain management, cold and allergy relief, diabetes, and muscle relaxation.